Can vision tests predict subsequent loss of acuity? The association between performance on several low contrast spatial vision measures, glare recovery, color discrimination, flicker sensitivity, stereopsis and ocular disease status at baseline and acuity loss 4.4 years later was examined in a large aged random sample with good initial acuity.
Introduction
Both cross-sectional and longitudinal studies show that vision function, most often measured as visual acuity, tends to decline in old age (Foran, Mitchell, & Wang, 2003; Haegerstrom-Portnoy, Schneck, & Brabyn, 1999; Klein, Klein, & Lee, 1996; Klein, Klein, Lee, Cruickshanks, & Chappell, 2001; Klein, Klein, Linton, & De Mets, 1991; Leibowitz et al., 1980; Rubin et al., 1997; Taylor, Livingston, Stanislavsky, & McCarty, 1997) . The decline in acuity with advancing age reflects both ''normal aging'' and the increased prevalence of disease that occurs with advancing age, most notably, cataract, age-related maculopathy, glaucoma and diabetic retinopathy (Attebo, Mitchell, & Smith, 1996; Elliott, Yang, & Whitaker, 1995; Frisen & Frisen, 1981; Gittings & Fozard, 1986; Kahn et al., 1977; Klein, Klein, & Linton, 1992a , 1992b Klein, Wang, Klein, Moss, & Meuer, 1995; Owsley, Sekuler, & Siemsen, 1983; Rahmani et al., 1996; Tielsch, Sommer, Witt, Katz, & Royall, 1990) .
The decline in mean acuity is associated with a dramatic increase in variability among individuals of a given age. This is true across age groups (e.g. Haegerstrom-Portnoy et al., 1999) as well as for longitudinal change across time. For example, participants in the Beaver Dam Eye study aged 43-54 years at baseline lost an average of 0.9 letters (standard deviation of 5.5) over a ten year period, whereas those 75 years and older at baseline lost an average of 11 letters (standard deviation of 20) over the same ten-year period (Klein et al., 2001 ). This pattern of results reflects the fact that some people show a large loss of acuity with advancing age while others maintain good acuity to much later ages. Being able to identify those individuals at risk for impending significant acuity loss would be beneficial in terms of identifying those most likely to benefit from intervention as well as for strengthening clinical trials of new potential sight-saving treatments.
Though eye disease is a risk factor for acuity loss, not all with diagnosed disease lose acuity even if the disease progresses.(e.g. Klein et al., 1995; Sunness et al., 1989 Sunness et al., , 1997 . Furthermore, among those with defined disease for which risk factors are known, only a small percentage with the risk factors and the disease may develop significant vision loss in the near future. For example, the Beaver Dam Eye Study followed a population for 10 years and confirmed that numerous soft drusen is a risk factor for progression to late-stage age-related macular degeneration (AMD), which is associated with significant vision loss (Klein, Klein, Tomany, Meuer, & Huang, 2002 ). Yet, even in the high risk group, the percentage who developed vision loss over the 10-year study period was only 15%, limiting the value of fundus appearance alone to identify those at risk for vision loss in this condition. Thus, even predicting significant future acuity loss among those with frank age-related disease is difficult. Sunness et al. (1997) found that, among individuals with geographic atrophy and relatively good acuity, other, non-standard measures of vision function were better predictors than fundus signs of significant acuity loss (doubling of visual angle) at follow-up two years later. Sunness et al. (1989) reported that, in a small study group of eyes with drusen with fellow eyes with AMD or drusen, foveal dark-adapted sensitivity was predictive of advanced AMD development.
The current study explores the potential of nonstandard, yet clinically-practical, vision tests to identify those individuals with relatively good acuity (20/40 or better) who will experience significant future loss of high contrast visual acuity when seen at follow-up approximately 4.4 years later. We restrict the analysis to those with initially good acuity to eliminate those with advanced disease, though eye disease was not an inclusion/ exclusion criterion. A cut-off of 20/40 was chosen based on common definitions of visual impairment (e.g. Dimitrov, Mukesh, McCarty, & Taylor, 2003) ; individuals within this acuity range qualify for drivers' licenses.
Methods

Sample
The group being followed in this longitudinal study has been described previously.(e.g. Haegerstrom-Portnoy et al., 1999) . The Smith-Kettlewell Institute (SKI) vision study group was derived from a larger randomly drawn sample in a study of health and functioning by the Buck Center for Research in Aging in Novato, CA (Reed et al., 1995) . Nine hundred community-dwelling individuals aged 58-102 (mean age 75.5 years; s.d. 9.3) had their vision tested at baseline. Five hundred and ninety six were re-tested an average of 4.4 years later (s.d. 1.02, range 2.1-6.8). The most common reason for loss to follow up was death (45.1% of those not re-tested). An additional 21.9% refused to participate for nonhealth reasons, and 15.0% refused because of health or physical problems, 13.7% moved out of the area and we were unable to contact the remaining 4.3%. 79.5% of eligible survivors were successfully re-tested.
Of the 596 individuals re-tested, 90% (537) had visual acuity of 20/40 or better at baseline. Medical eye records from optometrists and ophthalmologists were requested for all participants and were available covering the time prior to the baseline, during the period between tests and also after the retest for 88% of those with good acuity at baseline (472). Those without medical records providing information regarding eye health status and history, refractive error and visual acuity were eliminated from further analysis. For each individual, multiple records were obtained, covering a span of time from prior to baseline testing to post-follow-up testing. The 472 records were inspected to determine if the change in acuity at follow-up was most likely due to refractive causes and those participants were eliminated from further analysis (46). Refractive causes were assigned in cases wherein large changes of refraction between baseline and follow-up were noted upon examination of patient eye records. Thus, 426 participants are included in the following analyses. Each participant was classified in a binary fashion as having cataracts and/or retinal disease if present in one or both eyes at baseline based on the medical records. The average age at baseline of this group was 72.6 years (s.d. ¼ 7.8 years). This is somewhat younger than the 232 individuals lost to follow-up who had 20/40 or better acuity (76.1 years, s.d. 9.3). The other 24% of those lost to follow-up would have been excluded due to acuity worse than 20/40. The mean visual acuity of those considered here was 20=25 þ 2 ðlogMAR 0:06Þ, whereas the acuity of the 232 not retested but eligible was 20=25 ðlogMAR 0:1Þ.
Procedures
Written informed consent was obtained from all participants at both visits after explanation of the nature and possible consequences of the study and prior to testing. The research adhered to the tenets of the Declaration of Helsinki. The research was approved by the institutional review boards of the California Pacific Medical Center and Smith-Kettlewell Eye research Institute, San Francisco and the Buck Institute for Age Research.
The same procedures were used at the baseline and follow-up visits. At both, respondents were assessed using an extensive battery of vision tests including high and low contrast distance visual acuity (Bailey-Lovie charts at 3 m; Bailey & Lovie, 1976) , contrast sensitivity (Pelli-Robson chart at 3 m; 1 Pelli, Robson, & Wilkins, 1988) , low contrast acuity in veiling glare (Berkeley Glare Test at 40 cm; Bailey & Bullimore, 1991) , low contrast, low luminance acuity (SKILL Card dark chart at 40 cm; Haegerstrom-Portnoy, Brabyn, Schneck, & Jampolsky, 1997), mid-frequency flicker modulation threshold (large red target at 17 Hz), color vision (Farnsworth D-15 under Illuminant C; Farnsworth, 1947) , stereopsis (Frisby Test; Frisby, 1980) , glare recovery time (time to read line of SKILL Dark chart 2 lines (0.2 log unit) larger than previously measured threshold). Each of these tests has been described in detail elsewhere (Haegerstrom-Portnoy et al., 1999) . Because the broad goal of the study is to relate vision test results to performance of tasks of daily living and self-reported vision status, all measures were done binocularly with habitual distance or near correction, as appropriate.
Wherever possible, data are expressed in log units to facilitate direct comparisons. Letter chart tests were scored letter-by-letter and acuities are expressed as log MAR. On this logarithmic scale, 0.3 log unit reflects a doubling (or halving) of visual angle or acuity (e.g. 20/20 vs. 20/40, 20/100 vs. 20/200 etc.). For any measurement and scale, any 0.3 log unit difference reflects a factor of two on that particular measurement scale. Only color confusion score (CCS) of the D-15, the index of color vision defect severity, is considered on a linear scale (Adams & Haegerstrom-Portnoy, 1987 ); a CCS of 0 reflects perfect performance (no errors) on the test. A CCS of <30 has previously been used as a normal criterion for older observers (Haegerstrom-Portnoy et al., 1999) . Logistic regression models were used to investigate the relationship between the other (nonstandard) vision measures and subsequent visual acuity loss. The unit for logistic regression analyses for all vision measures other than color vision was 0.3 log unit, to reflect clinically meaningful differences. Because of the highly skewed distribution of the linear CCS, color discrimination was treated as a categorical variable (<30, 30 to less than 60, and P 60). The unit for age in the model was 5 years.
Because the inter-test interval varied somewhat among participants, acuity change was calculated as change per decade (10 · measured acuity change/intertest interval). This metric assumes a linear acuity change over time. However, acuity loss with age in the aged is exponential, so that our estimate of acuity loss is conservative (Haegerstrom-Portnoy et al., 1999) . A change of acuity of 0.3 log units/decade (a doubling of visual angle over that time) was considered clinically significant and is the functional outcome of the study. This criterion also facilitates comparison of our results to those of other studies with different inter-test intervals (e.g. Foran et al., 2003; Klein et al., 1996 Klein et al., , 2001 ).
Results
3.1. Vision characteristics at baseline for those with acuity of logMAR 6 0:30 (20/40 or better) Individuals with acuity of 20/40 or better (logMAR 6 0:30) showed considerable variation on many of the other vision measures at baseline, providing the opportunity to explore the association between these baseline test scores and the change in visual acuity that occurred between baseline and the follow-up examination (Fig. 1) . Virtually all individuals with good high contrast acuity had low contrast visual acuity better than log MAR 0.8 (20/125), (Fig. 1a) . Low contrast low luminance acuity and low contrast acuity in glare (Fig.  1b and c, respectively) showed poorer performance (distributions shifted to the left) and more variation than low contrast acuity. Contrast sensitivity (Fig. 1d ) spans 1.25 log units, though no-one with good standard acuity had extremely poor contrast sensitivity.
Non-spatial vision measures also showed substantial variation. Stereo acuity (Fig. 1e) spanned the full range of measurable performance (85 00 or better to worse than 340 00 at the 40 cm test distance used), though more than half the individuals had the finest stereo acuity measurable. Over 70% of this group made no errors on the D-15 (color confusion score (CCS) ¼ 0; Fig. 1f ), but there was considerable variation among the remainder. Time to recover spatial vision following exposure to glare (glare recovery, Fig. 1g ) varied from just a few seconds to more than 2.5 min. Threshold modulation depth for 17 Hz flicker (Fig. 1h ) also varied by more than a log unit.
Acuity change across time
The 5th and 95th percentiles of acuity change in this aged sample with good acuity at baseline were )0.64 log units per decade loss (6 lines plus 2 letters) and 0.27 log units per decade gain (2 lines plus 3.5 letters). More people showed a decline in acuity than an improvement. Approximately 63% changed 2 lines (0.2 log units) per decade or less, and 37% were within one line change per decade. Only 4.2% showed a significant improvement defined as 3 or more lines (0.3 log unit) per decade, whereas 4 times as many showed significant decline (16.9%). Fig. 2 shows the mean (±1 s.d.) acuity change across age. The mean acuity change is fairly small (0.10 log units, 5 letters/decade) and similar for all the age groups except for the oldest age group which shows a loss of 0.21 log units (10.5 letters) per decade. However, variability increases substantially across age (e.g. s.d. 0.20 vs. 0.44 for the youngest and oldest groups).
3.3. Association between scores on other vision measures at baseline and subsequent acuity loss Fig. 3a,b shows the percentage of people who developed significant acuity loss sorted by various levels of performance on two vision measures at baseline chosen to illustrate strong and weak associations with acuity loss. Low contrast low luminance acuity at baseline was among the measures strongly associated with future acuity loss (Fig. 3a) . No one with very good baseline low contrast low luminance acuity (SKILL Dark acuity better than log MAR 0.4 or 20/ 25) went on to have significant acuity loss, compared to 55% of those in the worst SKILL Dark acuity category (20/200 and worse). In fact, for every doubling of SKILL Dark chart acuity threshold (0.3 log unit difference), the percentage of people experiencing subsequent acuity loss approximately doubled. Log contrast sensitivity and low contrast acuity in glare produced very similar results (data not shown). Fig. 3b shows that subsequent acuity loss is independent of baseline sensitivity to 17 Hz flicker; only the slightest rise in the frequency of acuity loss is seen as modulation threshold is increased. Table 1 presents the odds ratios (OR, ±95% confidence interval (CI)) for the individual vision measures controlling for age. Odds ratios where the confidence interval excludes one are statistically significant. Significant odds ratios are indicated in bold type. The outcome measure was a decline in high contrast visual acuity of P 0.3 log units/decade at the follow-up test. Not surprisingly, age alone is associated with future acuity loss (odds ratio (OR) ¼ 1.39, 95% confidence interval 1.18-1.63) but gender was not. Each of the low contrast spatial vision measures, as well as color discrimination, stereopsis and glare recovery, were significantly associated with subsequent loss of high contrast acuity. Retinal disease status was also significantly associated with subsequent loss of high contrast acuity, but cataract status was not associated with future acuity loss. High contrast acuity at baseline was not predictive of future acuity loss.
Each of the low contrast spatial vision measures has an OR greater than 2.0 (2.19-3.61), indicating that for every unit difference in performance, the likelihood of subsequent acuity loss at least doubled. Poor stereopsis or poor color discrimination each increased the likelihood of future acuity loss about 1.7 times. Glare recovery time had an odds ratio of 1.3 times whereas sensitivity to 17 Hz flicker was not significantly associated with future acuity loss.
As has been described elsewhere (Haegerstrom-Portnoy, Schneck, Lott, & Brabyn, 2000) the spatial vision measures are highly correlated with one another within this sample.
2 To avoid problems of multi-collinearity, preliminary stepwise logistic regression was used to select the low contrast spatial vision variable to be used in the multivariate analyses. SKILL Dark chart (low contrast, low luminance) acuity had the highest Wald statistic (i.e. ratio of the unstandardized logit coefficient to its standard error; Hair, Anderson, Tatham, & Black, 1995) and was chosen for inclusion in the following analyses. In a multiple logistic regression analysis including all significant test and control variables from the univariate (a) (b) Fig. 3 . Vision function at baseline and the frequency of subsequent decline of standard visual acuity equivalent to 0.3 log units per decade is shown for two vision measures to illustrate strong (low contrast low luminance acuity, left), and weak (flicker sensitivity, right) associations. Each measure is plotted on a log scale, in 0.3 log unit bins, or a doubling of threshold between categories. Poorer function is to the right. 2 Despite the high correlations among measures and between each of the measures and standard high contrast acuity, it is not possible to predict performance on one measure from another with any reasonable accuracy For example, high contrast acuity and log contrast sensitivity are highly correlated in this sample (r ¼ 0:86). Yet, the 95th percent confidence interval for contrast sensitivity spanned approximately 1 log unit among individuals in this sample with equal acuity of 20/40 (log MAR 0.30). Thus, the measures are not 'redundant' with high contrast acuity.
analyses (age, retinal disease status, low contrast low luminance acuity, glare recovery, stereopsis and color vision), only low contrast low luminance acuity (OR 2.35, 95% CI 1.32-4.18) is a significant predictor of future acuity loss ( Table 2 ). None of the other vision measures remained significant in the multivariate analysis. Age also ceased to be a significant predictor when low contrast low luminance acuity (SKILL Dark chart acuity) was included in the model and retinal disease status also dropped out as a significant predictor. It should be noted that similar results would be obtained if other low contrast spatial vision measures such as low contrast acuity in glare or contrast sensitivity were included instead of the SKILL Dark chart acuity.
Discussion
The results demonstrate that simple, clinically-practical low-contrast tests of spatial vision are significant predictors of subsequent high contrast acuity loss in individuals who had fairly good acuity initially and who were not selected on the basis of disease status. For example, 55% of those in the worst category of low contrast low luminance acuity at baseline subsequently had significant acuity loss, compared to none of those with good initial low contrast low luminance acuity. The association between acuity loss and low contrast spatial vision measures was borne out in univariate regression analyses controlling for confounding factors, such as age, as well as multivariate analyses. Glare recovery time (retinal photostress), stereopsis and sensitivity to 17 Hz flicker were not significant predictors of future acuity loss in the multivariate analysis. These tests were initially included because each has been shown to be sensitive to early changes in retinal function associated with eye disease (AREDS, 2001; Mayer, Spiegler, Ward, Glucs, & Kim, 1992; Sandberg & Gaudio, 1995; Spafford & Lovasik, 1986) .
Retinal disease status, which was a significant predictor in the univariate analyses, dropped out in the multivariate analysis. It should be noted that a participant was assigned to the retinal disease category if either eye carried a diagnosis in the medical eye records.
16.9% of our aged sample with good initial acuity lost the equivalent of 3 or more lines of acuity per decade between baseline and follow-up an average of 4.4 years later. This is considerably higher than the rate (4.8%) among those with at least 20/40 in the Beaver Dam Eye Study (Klein et al., 2001 ) and most likely is attributable to the fact that our sample is considerably older than the Beaver Dam sample. Those authors report that the rate of significant acuity loss was 9 times higher among those aged 75 or older than among younger participants. The mean age of our sample was 72.6 years and 36% were aged 75 or older at baseline compared to less than 7% of the Beaver Dam sample which had a mean age of 58.7 years at baseline. 4.2% of the SKI study group showed significant improvement in acuity at re-test, compared to 3.9% of the Beaver Dam study group (worse eyes). Again, the somewhat higher rate in this study is likely attributable to our sample being much older than that of the Beaver Dam group; in that study significant improvement was twice as likely among those aged 75 and older than among younger persons, and was largely attributable to cataract extraction. Cataract surgery between baseline and follow-up was also the primary cause of acuity improvement in the Blue Mountains Eye Study (Foran et al., 2003) . In our study, 72% percent of those showing significant improvement in acuity had had intervening cataract surgery (or YAG capsulotomy) in one or both eyes compared to 8.2% of those who either showed no significant change or significant acuity loss. The improvement in acuity in many of those with a diagnosis of cataract at baseline no doubt contributed to the nearly significant odds ratio with reversed sign in the univariate analyses, indicating that cataract diagnosis tended to be associated with acuity improvement, rather than decline. Only 4 people had cataract surgery in between test times and suffered significant acuity loss at the follow-up; all had ocular disease diagnoses including complications from cataract surgery, glaucoma and ARM.
Some of the improvement observed in this study, which used habitual correction, may also have been due to improved refractive correction at the follow-up visit. We specifically examined all the medical records and eliminated those participants where it was likely that refractive changes were responsible for the improvement. Nonetheless, we cannot completely exclude refractive changes as the cause of the improvement. It is possible that uncorrected change in refractive error over time in this study may also have increased the frequency of acuity loss. Again, those observers whose records indicated that there had been a substantial change in refraction were eliminated from the analysis, but we cannot rule out refractive changes contributing to the loss. In any event, the change in refractive error among individuals in this study over the 4.4 year study period are likely to have been small. Lee, Klein, and Klein (1999) reported that in the Beaver Dam Eye Study, the mean 5-year change in refractive error among the aged was less than 0.2 D, and even in the extreme (severe nuclear sclerosis) only 0.5 D on average. Nearly half of that population over age 65 had a change of refractive error or 0.5 D or less.. As the population in the present study is of similar age, it is likely that these figures are applicable. It is very unlikely that such small changes in refractive error over time would produce the criterion 3-line change of acuity we report here. This is particularly true given the small pupils of the aged eye, and resultant large depth-offocus (e.g. Winn, Whitaker, Elliott, & Phillips, 1994) .
It is likely that ocular disease is a contributor to the loss in acuity. Of those who showed a subsequent significant loss of acuity, 37.5% had a diagnosis of ocular disease other than cataract at baseline. 38.9% had a cataract diagnosis at baseline in one or both eyes and 18.0% carried both a retinal diagnosis as well as cataract. The most common ocular diagnosis other than cataract was ARM (37% of retinal diagnoses). However, in the multivariate analysis, retinal disease status, which was a predictor in the univariate analyses, dropped out as a significant predictor when low contrast low luminance acuity at baseline was included in the model. What are possible mechanisms by which low contrast vision measures predict subsequent acuity loss? Low contrast vision tests are more sensitive to sub-clinical pathology present at the first test, which then became frank pathology affecting even high contrast acuity at follow-up. It has also been suggested that binocular summation and inhibition may play a role. Both binocular summation, which occurs if the two eyes have similar sensitivity, and binocular inhibition, observed in the presence of large inter-ocular differences in sensitivity (Pardhan & Gilchrist, 1990 ) are greater for low contrast than for high contrast targets (Cagenello, Arditi, & Halpern, 1993; Home, 1978) . If one eye was considerably worse than the other at baseline, one would predict that the better eye would predominate in determining standard high contrast acuity under the binocular conditions used here, whereas reduced summation or even inhibition might occur for low contrast tests, reducing measured performance. However, in our subsample with 20/40 or better binocular standard acuity, only 6.7% had large (P 4 lines) interocular acuity differences according to medical eye records. Of those with large interocular acuity differences, the majority (70%) did not show significant subsequent loss of acuity. Thus, while binocular summation/inhibition may have influenced the results slightly, these mechanisms do not account for the results.
The analysis described above was limited to the 426 participants with medical eye records and no obvious evidence of refractive error change, but 537 of the people who were re-tested had baseline high contrast visual acuity of 20/40 or better. If the data from all of these people (N ¼ 537) are included in the same kinds of analyses just presented (and refractive status, ocular disease status and presence of medical eye records is ignored), the results remain the same. The odds ratio for low contrast low luminance acuity in this case was 2.1 (CI 1.36-3.25) and age and gender were not significant predictors. This suggests that our main result that low contrast spatial vision measures predict future high contrast acuity loss is a robust finding.
Conclusions
The predictive power of these low contrast vision tests has implications for clinical monitoring and clinical trials of emerging therapies such as antioxidants and other supplements intended to slow or prevent vision loss. For example, the AREDS study (2001) applied such treatments to persons with age related maculopathy with mixed success. Using these other vision measures may enable future trials to target individuals most at risk for vision loss, and enable preventive treatments to be administered before serious vision loss occurs. Further, in many cases, the frequency of the adverse outcome of interest (development or progression of the disease or significant visual loss) is quite low, so that clinical trials must enroll very large numbers of participants, making them extremely costly and complex to carry out. By identifying those individuals most at risk, clinical trials could be conducted much more efficiently. In addition, the strong potential predictive power of these other tests suggest that they may serve as costeffective and practically-implemented screening tools for identifying those most at risk so that these individuals may be preferentially referred for care, making more efficient use of our limited health care resources.
The present findings also offer clinicians strong incentive to use low-contrast vision function tests to identify and recall patients at high risk for vision loss. In turn, the routine use of such tests will give the clinician (and the patient) a far better understanding of the degree of visual impairment faced by older patients in real world conditions. It is clear from our own experience that many patients do not presently have a good understanding of the nature of their own visual deficits and the means by which they can be overcome.
